# 3-Year Execution Roadmap: Epigenetic Deconvolution SaaS (ß-VAE)

## Executive Summary
This document outlines a 12-quarter (3-year) timeline to build, validate, and commercialize a machine learning platform capable of mathematically unmixing bulk epigenetic data into single-cell resolution. The project serves dual purposes: fulfilling the requirements of a Computer Science Ph.D. dissertation and functioning as the Minimum Viable Product (MVP) for a B2B clinical diagnostics software company.

---

## Year 1: The Anchor Model & Infrastructure
**Objective:** Build the automated data pipeline, engineer the core ß-Variational Autoencoder (ß-VAE), and validate the mathematical unmixing on a primary tissue type (Peripheral Blood Mononuclear Cells - PBMCs).

### Quarter 1: Infrastructure & Data Sourcing
* **Data Pipelines:** Write Python Bio.Entrez scripts to scrape the Human Cell Atlas (HCA) for pure single-cell PBMC reference data, and NCBI GEO for bulk PBMC holdout datasets.
* **Compute Environment:** Configure the local WSL 2/Docker development environment in Cursor.
* **Server Provisioning:** Provision the remote Hetzner compute cluster and establish the GitHub Actions CI/CD pipeline for automated training deployments.
* **Deliverable:** A populated, pre-processed HDF5 database of clean single-cell reference data and a verified connection between the local dev environment and remote GPUs.

### Quarter 2: The Pseudobulk Engine
* **Algorithm Design:** Engineer the Python "digital blender" script.
* **Simulation Loop:** Randomly sample and aggregate pure single-cell vectors to create 50,000+ simulated bulk tissue samples with known, perfect cellular ratios.
* **Deliverable:** The explicit ground-truth dataset required to train the optimizer. 

### Quarter 3: Core Architecture & Optuna NAS
* **PyTorch Engineering:** Draft the dynamic hourglass ß-VAE architecture with parameterized encoder/decoder depths and latent dimensions.
* **Hyperparameter Optimization:** Deploy Optuna to the Hetzner cluster. Execute massive search sweeps focusing on the latent dimension size (z) and the disentanglement penalty (ß).
* **Evaluation:** Optimize the network purely for the Concordance Correlation Coefficient (CCC) against the pseudobulk ground truth.
* **Deliverable:** An optimal, finalized network topology and highly accurate .pt weights for PBMC deconvolution.

### Quarter 4: Clinical Validation & First Publication
* **Real-World Testing:** Run the completely untrained, real-world clinical bulk samples (from Q1) through the optimized ß-VAE pipeline.
* **Analysis:** Calculate the variance between the software's mathematical unmixing and the physical wet-lab results.
* **Deliverable:** Draft and submit Chapter 1 of the dissertation / Paper 1: Optimizing ß-VAE Architectures for High-Fidelity Epigenetic Deconvolution in Whole Blood.

---

## Year 2: Multi-Tissue Generalization & Academic Defense
**Objective:** Prove the computer science architecture is universally applicable by extending it to solid tumors, finalizing the Ph.D. comparative framework.

### Quarter 1: Architecture Generalization
* **Data Sourcing II:** Scrape single-cell and paired bulk datasets for a completely different biological topology (e.g., Breast Cancer / BRCA microenvironments).
* **Pipeline Refinement:** Abstract the pseudobulking Python script to dynamically handle varying tissue structures without requiring hardcoded logic changes.
* **Deliverable:** A generalized ETL pipeline capable of digesting any tissue type from open-source databases.

### Quarter 2: Parallel Optuna Studies
* **Transfer Learning / Warm Starts:** Spin up new Optuna studies for the solid tumor datasets, seeding the optimizer with the best spatial hyperparameter dictionaries discovered in Year 1.
* **Compute Scaling:** Monitor the Hetzner server load as multiple disease-specific networks train simultaneously.
* **Deliverable:** A suite of specialized .pt weight files, each expertly tuned for a specific tissue type.

### Quarter 3: The Comparative Analysis
* **Data Aggregation:** Aggregate the validation metrics across the distinct tissue models. 
* **Mechanistic Discovery:** Map the latent spaces of the different models to mathematically prove why a ß-VAE must be uniquely tuned per tissue type, highlighting the algorithm's adaptability.
* **Deliverable:** Draft and submit Chapter 2 / Paper 2: A Comparative Framework for Multi-Tissue Epigenetic Deconvolution.

### Quarter 4: The Ph.D. Capstone
* **Dissertation Assembly:** Bind the data engineering, network architecture search, and multi-tissue comparative analyses into the final dissertation format.
* **Defense Preparation:** Finalize the presentation focusing strictly on the high-performance computing constraints, the Optuna optimization strategy, and the novel loss function metrics.
* **Deliverable:** Successfully defend the Computer Science Ph.D.

---

## Year 3: SaaS Transformation & Commercial Handoff
**Objective:** Transition the validated academic codebase into a scalable, secure, and licensable enterprise API platform.

### Quarter 1: The API Routing Engine
* **Backend Engineering:** Wrap the specialized PyTorch inference models in a high-performance Python framework (like FastAPI).
* **Smart Routing:** Build the metadata parser that reads incoming clinical CSVs and instantly routes them to the correct, tissue-specific Hetzner inference container.
* **Deliverable:** A functioning, private API gateway capable of receiving data and returning a JSON single-cell payload.

### Quarter 2: Security & LLC Infrastructure
* **Access Control:** Implement API key generation, rate limiting, and OAuth2 security protocols for client verification.
* **Data Privacy:** Ensure the pipeline is completely stateless—clinical data is unmixed in memory and instantly wiped from the Hetzner servers post-inference.
* **Deliverable:** A production-ready, secure inference platform operating under the legal framework of the Florida LLC.

### Quarter 3: The Clinical Beta Test
* **Onboarding:** Partner with a single, mid-sized bioinformatics lab or university research team. Provide them with free/discounted API tokens.
* **Stress Testing:** Allow the partner to run massive batches of cheap bulk sequencing data through the pipeline. Monitor Hetzner compute costs versus API response times.
* **Deliverable:** A case study proving the software saved the partner lab ,000 in physical sequencing costs over a 3-month period.

### Quarter 4: Commercial Launch & Scale
* **Productization:** Finalize the API documentation and developer portal.
* **Pricing Model:** Establish the SaaS tiers based on Hetzner compute margins (e.g., charge per megabyte of bulk data processed, or a flat monthly enterprise license).
* **Deliverable:** Public launch of the \\Virtual Centrifuge\\ platform.
